Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlaxoSmithKline PLC

40.19
+0.11000.27%
Pre-market: 40.280.0900+0.22%08:17 EDT
Volume:3.40M
Turnover:137.00M
Market Cap:81.83B
PE:17.75
High:40.57
Open:40.36
Low:40.08
Close:40.08
52wk High:44.67
52wk Low:31.72
Shares:2.04B
Float Shares:1.95B
Volume Ratio:1.09
T/O Rate:0.17%
Dividend:1.65
Dividend Rate:4.10%
EPS(TTM):2.26
EPS(LYR):1.58
ROE:28.33%
ROA:6.78%
PB:4.10
PE(LYR):25.41

Loading ...

GSK Announces Transaction for Chief Digital Officer

TIPRANKS
·
Aug 21

GSK Advances Wednesday, Outperforms Market

Dow Jones
·
Aug 21

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
Aug 20

GSK Enhances Shareholder Value with Strategic Share Buyback

TIPRANKS
·
Aug 20

GSK Executives Acquire ADSs Through Dividend Reinvestment

TIPRANKS
·
Aug 19

GSK Rises Monday, Outperforms Market

Dow Jones
·
Aug 19

GSK and iTeos Advance Immunotherapy Study for Lung Cancer

TIPRANKS
·
Aug 16

GSK Executives Acquire Shares Under Reward Plan

TIPRANKS
·
Aug 12

Barclays Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Aug 12

GSK Advances Share Buyback Program with Recent Share Acquisition

TIPRANKS
·
Aug 11

GSK’s Phase 3 Study on Dostarlimab: A Potential Game-Changer in Colon Cancer Treatment?

TIPRANKS
·
Aug 09

Top Midday Stories: Trade Desk CEO Says Tariffs Impacting Key Clients; UK Regulator Approves Boeing's Acquisition of Spirit AeroSystems

MT Newswires Live
·
Aug 08

GSK Advances Share Buyback Program with Latest Purchase

TIPRANKS
·
Aug 08

GSK’s Phase 3 Malaria Study: A Potential Game-Changer for Tafenoquine in India

TIPRANKS
·
Aug 08

GSK’s New Vaccine Study: What Investors Need to Know

TIPRANKS
·
Aug 08

IDEAYA (IDYA) Q2 Net Loss Improves 27%

Motley Fool
·
Aug 06

GSK’s RSV Vaccine Study: A Potential Game-Changer for Older Adults

TIPRANKS
·
Aug 06

GSK Continues Share Buyback Program with Recent Purchase

TIPRANKS
·
Aug 05

GSK price target lowered to 1,400 GBp from 1,460 GBp at JPMorgan

TIPRANKS
·
Aug 05

J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Aug 04